High Performance Liquid Chromatography (HPLC) Method for Analysis of Buprenorphine and Naloxone on Primesep 100 by SIELC Technologies
Separation type: Liquid Chromatography Mixed-mode

Buprenorphine is an opioid partial agonist used to treat Opioid Use Disorder (OUD). Naloxone is used to treat the effects of opioids as part of a treatment for opiate addictions. When placed together in a sublingual film, they can be quite effective at treating opiate/narcotic addictions non-addictively. Buprenorphine and Naloxone can be separated, retained, and analyzed on a Primesep 100 mixed-mode stationary phase column using an gradient analytical method with a simple mobile phase of water, Acetonitrile (MeCN), and a sulfuric acid (H2SO4) buffer. This analysis method can be detected in the UV regime at 280 nm.
High Performance Liquid Chromatography (HPLC) Method for Analyses of Buprenorphine and Naloxone
Condition
| Column | Primesep 100, 4.6 x 150 mm, 5 µm, 100 A, dual ended |
| Mobile Phase | Gradient MeCN |
| Buffer | H2SO4 – 0.2% |
| Flow Rate | 1.0 ml/min |
| Detection | UV,280 nm |
| Peak Retention Time | 3.8, 8.2 min |
Description
| Class of Compounds | Drugs |
| Analyzing Compounds | Buprenorphine, Naloxone |
Application Column
Primesep 100
Column Diameter: 4.6 mm
Column Length: 150 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: dual ended
Buprenorphine hydrochloride
Naloxone
Naloxone chlorhydrate



